Soluble interleukin-1 receptor type II levels are elevated in cerebrospinal fluid in Alzheimer's disease patients
Authors:
- Anita GarlindAGAnita Garlind
- Annelie BraunerABAnnelie Brauner
- Bo HöjebergBHBo Höjeberg
- Hans BasunHBHans Basun
- Marianne SchultzbergMSMarianne Schultzberg
- 1 April 1999
- journal article
- Published by Elsevier in Brain Research
- Vol. 826 (1) , 112-116
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Kainic acid induced expression of interleukin-1 receptor antagonist mRNA in the rat brainMolecular Brain Research, 1998
- tau protein in cerebrospinal fluidMolecular and Chemical Neuropathology, 1995
- Interleukin-1β and interleukin-6 are elevated in the cerebrospinal fluid of Alzheimer's and de novo Parkinson's disease patientsNeuroscience Letters, 1995
- Reciprocal control of inflammatory cytokines, IL-1 and IL-6, and β-amyloid production in culturesNeuroscience Letters, 1995
- Interleukin-1 Type II Receptor: A Decoy Target for IL-1 That Is Regulated by IL-4Science, 1993
- Microglia and cytokines in neurological disease, with special reference to AIDS and Alzheimer's diseaseGlia, 1993
- β-Amyloid stimulates glial cells in vitro to produce growth factors that accumulate in senile plaques in Alzheimer's diseaseBrain Research, 1992
- Interleukin‐6 and α‐2‐macroglobulin indicate an acute‐phase state in Alzheimer's disease corticesFEBS Letters, 1991
- Immunochemical identification of the serine protease inhibitor α1-antichymotrypsin in the brain amyloid deposits of Alzheimer's diseaseCell, 1988
- Immunoglobulins and complement factors in senile plaquesActa Neuropathologica, 1982